Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-01

Clinical Trial Update: Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome [Phase 1, Phase 2]

View source ↗

Summary

Preliminary (Phase 1/2) trial updates on the effect of a high bolus dose of tirofiban given upstream in primary PCI for STEMI, status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tirofiban (tirofiban)

Snippet

Sponsor: Assiut University | Conditions: High Bolus Dose of Tirofiban | Phase 1, Phase 2 | Status: UNKNOWN